Registry and Reporting. Sponsor will adhere to the ICMJE requirements on clinical trial registration and represents that the Trial will be registered according to ICMJE applicable requirements and all applicable laws regarding clinical trial registration prior to the recruitment of the first Trial Participant and will report the results of the Trial publicly when and to the extent legally required.
Registry and Reporting. Without limitation to any other right of Sponsor hereunder, the Institution acknowledges and agrees that Sponsor will register the Study and, when available, post the Multi-Center Study Results in accordance with Sponsor internal policy on one or more publicly-accessible trial registries and websites (including the publicly- funded website (xxxx://xxx.xxxxxxxxxxxxxx.xxx/) and on its own website (xxxx://xxx.xxxxxxxxxxxxxxxxxxxxxxxxx.xxx). The Institution should not undertake registration or posting of results to avoid duplication of entries and avoid disclosure of Confidential Information. Sponsor personnel must comply with local/national law and/or regulations which require registration of study information to a Autori publikácií zverejnia každý potenciálny konflikt záujmov, vrátane všetkých finančných alebo osobných vzťahov, ktoré by mohli mať vplyv na nestrannosť ich práce. Skúšajúci sa zaväzuje zverejniť všetky ďalšie informácie požadované akýmkoľvek zdravotníckym zariadením alebo vedeckou inštitúciou, lekárskym výborom alebo inou lekárskou alebo vedeckou organizáciou, ktorej je členom.
Registry and Reporting. Sponsor will adhere to the ICMJE requirements on clinical trial registration and represents that the Trial will be registered according to ICMJE applicable requirements and all applicable laws regarding clinical trial registration prior to the recruitment of the first Trial Participant and will report the results of the Trial publicly when and to the extent legally required. Institution and Investigator acknowledge that, Sponsor may, in accordance with the joint ‘Principles for Responsible Clinical Trial Data Sharing’ by EFPIA and PhRMA (found at: xxx.xxxxx.xx or xxx.xxxxx.xxx), share the clinical study report, related clinical documents, and patient-level clinical study data with third party requestors (more information to be found at xxxx://xxxxxx.xxxxxxxxxx- xxxxxxxxx.xxx/xxxxxxxxxxxx_xxxxxx.xxxx).
Registry and Reporting. Without limitation to any other right of Sponsor hereunder, the Institution and the Investigator acknowledge and agree that Sponsor will register the Study and, when available, post the Multi-Center Study Results in accordance with Sponsor internal policy on one or more publicly-accessible trial registries and websites (including the publicly-funded website XxxxxxxxXxxxxx.xxx and on its own website XxxxxXxxxxxXxxxxxxxXxxxxx.xxx). The Institution and the Investigator should not undertake registration or posting of results to avoid duplication of entries. Sponsor personnel must comply with local/national law and/or regulations which require registration of study information to a publicly-accessible registry other than those named above. Where the Institution and the Investigator wish to use a publicly- accessible website on a voluntary basis (e.g. a university/hospital website) the information related to the Protocol must not exceed the information Sponsor has already posted and it should be sufficient to provide a hyperlink to the trial when registered on xxx.XxxxxxxxXxxxxx.xxx. d)
